Brace yourself! This week, we’re learning about cerebral palsy from Dr. Matthew MacCarthy, who is both a pediatric physical medicine and rehabilitation (PM&R) specialist at Prisma Health in South Carolina AND a person with cerebral palsy. We’re talking NICU, Botox, and puberty, so get ready to stretch your knowledge with a thoughtful approach to CP diagnosis and management.
Cerebral palsy is a broad umbrella term and will look different for different people.
The most common cause is periventricular leukomalacia (damage to brain tissue surrounding the ventricles), typically from intraventricular hemorrhage. Other causes include other forms of neonatal stroke and hypoxic-ischemic encephalopathy (HIE). HIE typically occurs when infants don’t get enough oxygen at some point in the birth process. Infections, like TORCHES infections or chorioamnionitis, can also cause brain injury. Genetic diagnoses are a little more complex. If an infant has a genetic disorder that causes structural brain malformations and results in a non-progressive movement disorder, some clinicians would diagnose CP and others wouldn’t.
Prematurity is a strong risk factor, and risk increases dramatically with decreasing gestational age.
Gestational age | Hazard ratio for development of CP compared to term infants (39-40 weeks) |
35-36 weeks | 2-3 times more likely |
32-24 weeks | 6-9 times more likely |
28-31 weeks | 16-33 times more likely |
25-27 weeks | 24-54 times more likely |
22-24 weeks | 47-84 times more likely |
However, term infants can still develop CP!
Other risk factors include multiple gestation, maternal infection, coagulopathies (either bleeding or clotting disorders), and maternal chronic disease. Lower socioeconomic status has also been shown to be an independent risk factor, although the exact mechanism is unknown.
Symptoms are determined by the location and nature of brain injury, and symptoms vary a lot from person to person. According to Dr. MacCarthy, “there are essentially as many manifestations of CP as there are people with it.”
Spasticity is the most common motor manifestation of CP. Spasticity is a velocity-dependent increase in muscle tone caused by abnormal motor signaling in the brain and spinal cord. It feels like muscle resistance to passive stretch that is continuous (as opposed to clonus, which is rhythmic). Usually spasticity does not cause pain, so only needs to be treated to improve function or ease of care.
Expert tip: Dr. MacCarthy points out that cognitive impairment is common, not universal. Also, it can be challenging to accurately assess cognition in people who have severe motor symptoms and/or speech challenges, so we may be underestimating cognitive function in those patients. Many people with CP have typical cognition, so assume typical cognition until proven otherwise.
Because symptoms of CP may not develop for months after birth, children are typically diagnosed between 6-18 months of age.
Infants at high risk of CP (e.g. micropremies) should ideally already be connected with services to monitor for early signs of CP, like NICU follow up clinics. Diagnosis can be more challenging and happen later in otherwise-healthy term infants.
When Dr. MacCarthy is approaching a later diagnosis of CP, he emphasizes a few things.
Order a brain MRI without contrast, which will show damage in over 80% of cases. Head ultrasound can be used in the NICU to look for a more acute injury, like intraventricular hemorrhage, but MRI is best for detecting remote injury.
Botulinum toxin (one brand name is Botox) causes local neuromuscular blockade by inhibiting the protein complex that facilitates presynaptic fusion of acetylcholine vesicles. It works well for focal spasticity and has no systemic side effects.
Botulinum toxin is dosed up to every 3 months. While its effects may wear off before 3 months, more frequent treatments are associated with antibody formation.
Botulinum toxin can be used in combination with orthotics to help relax a muscle before bracing it in a stretched position.
Baclofen is best for widespread spasticity. The downside of an enteral medication is the systemic side effects, including sedation, worsening central hypotonia, and theoretically lowering seizure threshold (so check with their neurologist if the patient has epilepsy).
Baclofen dosing varies. Dr. MacCarthy typically starts with 0.25 mg/kg given at bedtime for 1 week, then 0.5 mg/kg per day divided into two doses for 1 week. He’ll then increase the dose by approximately 50% of the starting dose per week until symptoms are controlled. A typical therapeutic dose is somewhere around 1-2 mg/kg per day divided into two or three doses. The maximum dose is limited by side effects, mostly sedation.
If local or enteral medications aren’t sufficient for symptom control, neurosurgery can sometimes place an intrathecal baclofen pump to deliver baclofen directly into the CNS. This is a very specialized procedure that requires very careful patient selection.
Benzodiazepines can be used as an alternative to baclofen in children with epilepsy. Dr. MacCarthy typically doesn’t combine with baclofen due to high chance of sedation.
Many children with CP benefit from orthotics or braces (those terms are interchangeable) to help stretch areas of spasticity and improve range of motion. Specific orthotics vary based on the child and the affected muscles.
Barring any pituitary issues, CP shouldn’t affect pubertal development. You should talk with adolescents with CP about puberty, relationships, and sex, and general anticipatory guidance is usually appropriate.
Providers often incorrectly assume that people with cerebral palsy (or other disabilities) don’t have romantic or sexual relationships. People with cerebral palsy are also at increased risk of experiencing sexual dysfunction or interpersonal or sexual violence, which makes counseling about healthy relationships even more important.
In Dr. MacCarthy’s experience, many adult providers aren’t as familiar with CP and adult care can be more fragmented. He recommends starting the process of transitioning to adult care early. There’s still lots of work to do to spread awareness about CP within internal medicine!
State of the Evidence Traffic Lights 2019: Systematic Review of Interventions for Preventing and Treating Children with Cerebral Palsy: A comprehensive systematic review that assesses evidence for all CP treatment modalities.
American Academy of Cerebral Palsy and Developmental Medicine annual conference: A multidisciplinary event great for people interested in learning more about CP.
Listeners will explain the basic pathophysiology, diagnosis, and management of cerebral palsy throughout the pediatric lifespan using a multispecialty approach.
After listening to this episode, listeners will be able to:
Dr. MacCarthy reports no relevant financial disclosures. The Cribsiders report no relevant financial disclosures.
Lidsky H, MacCarthy M, Masur S, Chiu C, Berk J. “#141: Cerebral Palsy from Birth to Adolescence: CP (Clinical Pearls) for CP”. The Cribsiders Pediatric Podcast. https:/www.thecribsiders.com/ May 7, 2025.
Factor is offering Cribsiders listeners 50% off chef-made, gourmet meals that are ready in 2 minutes. Use code “cribsiders50off” to get 50% off your first box plus free shipping.
Freed, an AI scribe that listens, transcribes, and writes medical documentation for you, is offering all Cribsiders listeners $50 off their first month with code CURB50 at freed.ai.
Producer, Writer, and Infographic: Hartlee Lidsky
Showrunner and Host: Sam Masur, MD
Cover Art and Host: Chris Chiu, MD
Editor: Clair Morgan of nodderly.com
Guest: Matthew MacCarthy, MD
The Cribsiders have partnered with Penn Medicine Continuing Education to offer continuing education credit—including AMA PRA Category 1 Credit™ and ABP MOC Part 2—for physicians and other healthcare professionals. An annual subscription gives you unlimited access to the full course catalog. Enrol Now.
Got feedback? Suggest a Cribsiders topic. Recommend a guest. Tell us what you think.
We love hearing from you.

Yes, you can now join our exclusive community of core faculty at Kashlak Memorial Hospital along with all the perks:
Notice
We and selected third parties use cookies or similar technologies for technical purposes and, with your consent, for other purposes as specified in the cookie policy. Denying consent may make related features unavailable.
Close this notice to consent.